Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients
NCT05188326
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
DRUG:
Vidaza 100 milligram (mg) injection
OTHER:
Best Supportive Care
Sponsor
Associazione Qol-one